UnknownNot Applicable

Efficacy of Luteinizing Hormone (LH) Activity in Low Responder Patients With Transdermal Testosterone

Spain104 participantsStarted 2011-01

Plain-language summary

The investigators have previously demonstrated the utility of transdermal testosterone in in vitro fertilization (IVF) low responder patients. Now, the investigators want to evaluate the efficacy of luteinizing hormone (LH) activity added to recombinant follicular stimulating hormone (FSHr) during ovarian stimulation in these patients.

Who can participate

Age range18 Years – 41 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Low responder patients: patients with previously canceled cycle or recovery of 3 or less oocytes Exclusion Criteria: * FSH \> 12 * Previous ovarian surgery

What they're measuring

ovarian response

Timeframe: within 2 weeks after begining ovarian stimulation

Trial details

NCT IDNCT01291212

SponsorHospital Clinic of Barcelona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-06

View on ClinicalTrials.gov More Other Complications Associated With Artificial Fertilization trials